During a press conference on Wednesday, chief medical advisor with the regulatory branch of Health Canada Dr. Supriya Sharma stressed that the approval of the Pfizer coronavirus vaccine came after a rigorous review of clinical trial data, and emphasized that the health agency authorized the drug after finding no serious safety concerns and Canadians should “absolutely” feel comfortable getting it.